Investment in Pharma Stocks in BSE: A Performance Analysis Muduli Rupal1,*, Das Udayan2,** 1Graduated Student, PGDM 2015–17, Asian School of Business Management, Bhubaneswar 2Professor, Asian School of Business Management, Bhubaneswar *Corresponding Author E-mail rupalmuduli94@gmail.com
**prof.udayandas@gmail.com
Online published on 2 June, 2018. Abstract Many of the investors may feel a great opportunity to make profit in the stock market while many consider it too risky to invest. The opinion differs from person to person, investor to investor. The high level of volatility may lead to the substantial losses for many investors. There are many responsible factors. One needs to develop a bird's eye view over the stock market and analyse every factor with proper tools and techniques so that she/he may not go wrong in the investment decision. A detailed analysis may help the investors by reaching into a rational conclusion to optimise the gain or at least reducing the chance of losing money. The study deals with fundamental analysis to reach at a rational investment decision concentrating on Indian pharma stocks. It finally arrives at the optimum choice for investment by considering thirteen identified stocks of the Indian pharma sector based on six different parameters comparing the performances during last five years. This study is expected to reduce the ambiguity in the minds of investors regarding various facets of investment in the stock market. Top Keywords Pharma Sector, Return on equity, Return on Assets, Market capitalisation, PE Ratio, Dividend per share, Beta. Top |